Description
Sunitinib reduces physical activity (assessed with a pedometer) in a patient with metastatic kidney cancer: a case study
€2.42
Sunitinib reduces physical activity (assessed with a pedometer) in a patient with metastatic kidney cancer: a case study
Reviews
There are no reviews yet.